TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
GRAL

GRAIL, LLC

Healthcare · Diagnostics & Research

80.80$ +1.0% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement GRAL
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0%
784.4% 309.6% 202.7% 162.1% 142.5%
-684.4% -209.6% -102.7% -62.1% -42.5%
3,149.5% 593.3% 363.8% 256.7% 133.0%
1,235.5% 313.4% 215.1% 170.3% 108.1%
7,975.2% 9,588.6% 1,524.9% 1,680.9% 320.4%
-8,659.6% -9,798.2% -1,627.6% -1,743.0% -363.0%
-8,659.0% -9,795.5% -1,619.3% -1,721.7% -363.2%
-119.6% -76.1% -45.1% -107.8% -85.7%
-8,539.4% -9,719.3% -1,574.2% -1,613.9% -277.5%
-8,259.0% -1,058.0% -685.5% -485.8% -257.0%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?